Bob Root

Bob Root is a former High Tech CEO from Silicon Valley (San Jose, California). After his wife and Keys co-founder, Wendy Steele, a former Coca Cola Vice President, was struck with Melanoma, Bob began to research and study skin conditions. Later when the prescriptions for creams and sunscreens made Wendy’s skin worse, he began to develop products for her that was chemical-free and therapeutic. When Wendy exhibited what looked like eczema, adult acne, rosacea and psoriasis, he turned to his engineering background to look for ancient remedies using modern technologies to improve on these tried and true natural medicines. These remedies became the foundation of what is today, Keys Care, Inc.

Bob is the Chief technology Officer for Keys Care Inc. His background is mechanical engineering and quantum physics with most studies in the area of nano-machines and nanotechnology. He is responsible for the design, development and manufacturing of Keys products. Keys develop and manufacture natural skin medicines that are chemical-free, vegan, gluten-free and therapeutic for people and their pets. Keys products follow an algorithm of pharmaceutical grade natural ingredients in therapeutic proportions. These are ancient remedies employing modern process technologies. Keys products carry the best safest product ratings by the EWG Skin Deep Report and their Solar Rx sunblock was ranked the most effective by Consumer reports Magazine (July 2007). Bob is affiliated with The University of Maryland School of Medicine, Ohio State University, San Diego State University and Los Alamos National Labs. He is a member of the Safe Cosmetics Campaign and Keys is a SafeCosmetics.org compact signer. Bob is also affiliated with the Natural Products Manufacturers Association and a member of numerous industry associations. He is the author of the book, “Defining Moments” and is in the process of writing a new book with the working title of “Chemical Warfare.” Bob has spoken at The Natural Products Expo trade shows, The Environmental Working Group, Cambridge Nano-Pharmacology Conference and many local events.